Case File
efta-efta00763699DOJ Data Set 9OtherDS9 Document EFTA00763699
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00763699
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: "Jeffrey Epstein" <[email protected]>
Subject: EMI worth £2bn less than we paid, Hands says
Date: Mon, 15 Feb 2010 11:15:13 +0000
Importance: Normal
EMI worth £2bn less than we paid, Hands says
By Andrew Edgeclif fe-Johnson
Published: February 14 2010 22:46 I Last updated: February 14 2010 22:46
Guy Hands, the boss of private equity group Terra Firma, has admitted EMI is worth £2bn
(83.1bn) less than he paid for it in 2007, in a calculation that could provide a valuation
benchmark for any future sale of all or part of the indebted music company behind Coldplay
and Lily Allen.
Mr Hands wrote last November to Citigroup <http://markets.ft.com/tearsheets/performance.asp?
s=us:C> , the bank that financed the ill-fated £4.2bn takeover by Terra Firma, proposing a
"complete restructuring of EMI" based on a new enterprise value of just £2.2bn.
The letter, filed by Citigroup with a New York court on Friday, is the first official
acknowledgement that Terra Firma's equity is all but worthless.
Mr Hands offered to raise £lbn of new equity if Citigroup would write off £lbn of debt,
before suing the bank after it turned his offer down.
Mr Hands' proposal <http://www.ft.com/cms/s/0/2d1fe7b2-ecOb-11de-8070-00144feab49a.html>
valued EMI Music Publishing at £1.46bn and EMI Music, its record company, at less than £800m.
Terra Firma has written down its original equity by 90 per cent.
The offer "would enable Citi to realise a certain and quick recovery" at a significant
premium to the valuation of Warner Music, EMI's closest rival, he argued. Citi refused to
write off debt without getting something in return, saying it did not see "sufficient value".
The letter discloses that Mr Hands offered to split EMI in two, a move that could have
ringfenced its more stable music publishing arm, protecting that part of Terra Firma's
investment should EMI Music breach covenants on Citigroup's loans, as it now risks doing.
Separating recorded music from music publishing could also have paved the way for a sale of
one or both divisions, according to a person close to the company. Another person close to
the company said this was not Mr Hands' motivation. Mr Hands' statement that he believed
Terra Firma and Citigroup were "in agreement in relation to a number of key components of an
acceptable solution, including the need to separate the two businesses", is likely to
encourage would be-bidders.
Warner Music has said it sees no regulatory hurdles
<http://markets.ft.com/tearsheets/performance.asp?s=us:WMG> to a bid for EMI Music. Industry
observers believe EMI Music Publishing would attract offers from private equity firms and
pension funds should it come up for sale.
Mr Hands' letter highlights his concern about "adverse publicity" if no agreement were
reached with Citigroup before his EMI acquisition vehicle filed accounts for the year to
March3.Thoseaccounts, released this month, showed auditors had "significant doubts" about
the company's ability to continue as a going concern.
Terra Firma now needs to raise £120m from investors by June, or risk losing control of EMI to
Citigroup.
The letter also shows concern about EMI's pension liabilities
EFTA00763699
<http://www.ft.com/cms/s/0/33e0bc9c-11cd-lldf-b6e3-00144feab49a.html> . The proposal to
Citigroup included injecting £75m upfront to the pension scheme and m in payments over nine
years.
Citigroup, which denies Terra Firma's claim that it fraudulentlymisrepresented the position
of a rival bidder in the 2007 auction, said in its court submission that a London trial would
not jeopardise the Terra Firma chairman's status as a tax exile in Guernsey.
Terra Firma argued this month that the case belonged in New York.
This message is confidential. It may also be privileged or otherwise
protected by work product immunity or other legal rules.
If you have received it by mistake please let us know by reply and then
delete it from your system;
you should not copy the message or disclose its contents to anyone.
Opinions, conclusions and other information in this message that do not
relate to the official business of Asia Gateway Ltd.
shall be understood as neither given nor endorsed by it.
Asia Gateway Ltd.
Michelin House
81 Fulham Road
London SW3 6RD
UK
Tel:
Fax:
EFTA00763700
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://markets.ft.com/tearsheets/performance.aspURL
http://markets.ft.com/tearsheets/performance.asp?s=us:WMGURL
http://www.ft.com/cms/s/0/2d1fe7b2-ecOb-11de-8070-00144feab49a.htmlURL
http://www.ft.com/cms/s/0/33e0bc9c-11cd-lldf-b6e3-00144feab49a.htmlRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.